Home/Filings/4/0001209191-13-054608
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001209191-13-054608

$NBYCIK 0001389545operating

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 2:40 PM ET

Size

5.3 KB

Accession

0001209191-13-054608

Insider Transaction Report

Form 4
Period: 2013-04-29
Li Xinzhou
10% OwnerOther
Transactions
  • Other

    Common Stock

    2013-04-29+1,7432,001,743 total(indirect: By Pioneer Pharma (Singapore) Pte. Ltd.)
Footnotes (2)
  • [F1]The shares were issued pursuant to an International Distribution Agreement dated as of September 13, 2012, between the Issuer and an affiliate of Pioneer Pharma (Singapore) Pte. Ltd.
  • [F2]The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., which is a wholly owned subsidiary of Pioneer Pharma Co. Ltd., of which the Reporting Person and his spouse are the sole owners. The Reporting Person's previous Form 3 and Form 4 filings incorrectly stated that Pioneer Pharma (Singapore) Pte. Ltd. was a wholly owned subsidiary of Naqu Area Pioneer Pharma, Co. Ltd.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 2:40 PM ET
Size
5.3 KB